Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PROP Paired-Like Homeobox 1 (PROP1) (Middle Region) Peptide

PROP1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN982252

Quick Overview for PROP Paired-Like Homeobox 1 (PROP1) (Middle Region) Peptide (ABIN982252)

Target

PROP1 (PROP Paired-Like Homeobox 1 (PROP1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-PROP1 antibody (Catalog #: ARP38767_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PROP1 (PROP Paired-Like Homeobox 1 (PROP1))

    Background

    PROP1 has both DNA-binding and transcriptional activation ability. Its expression leads to ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes, and caudomedial thyrotropes. Inactivating mutations in PROP1 result in deficiencies of

    Alias Symbols: CPHD2, PROP-1

    Protein Interaction Partner: HESX1,PITX2

    Protein Size: 226

    Molecular Weight

    25 kDa

    Gene ID

    5626

    NCBI Accession

    NM_006261, NP_006252

    UniProt

    O75360
You are here:
Chat with us!